At our Wilmington Biotech Campus, we are committed to keeping the patient at the very heart of all that we do and strive to find solutions and treatments for some of the world’s most challenging healthcare needs. The Wilmington Biotech Campus will play a pivotal role in the manufacture of our company's biologics-based medicines, including in the area of immuno-oncology. This site will establish our company's internal capability to manufacture high potent compounds when full manufacturing operations begin in 2029. This facility will be a significant supplier of Antibody Drug Conjugates and High Potent Compounds and will also be critical in the future supply of new biotechnology products to its global network. Wilmington Biotech Campus - Analytical Development and Quality Control Laboratory The Analytical Development and Quality Control Laboratory at Wilmington Biotech Campus will be a transformational facility for the analytical commercialization of our company's pipeline of high potent Biologics including deep pipeline of Antibody Drug Conjugates. This laboratory will bring together late-stage analytical method development and validation with commercial release testing to deliver significantly improved speed through the analytical lifecycle. The laboratory will be supported by locally based advanced analytical subject matter experts and digital tools to enable an enterprise-wide connected laboratory in support of a new approach to analytical commercialization for high potent Biologics. The laboratory will be operated in collaboration by our Research and Development and Manufacturing Divisions. Reporting to the Vice President, Global Quality Large Molecule Analytical Science (GQMAS), the Site Analytical Development and Quality Control Lead is accountable for establishing a transformational approach to the commercialization of analytical methods for high potent Biologics at the Wilmington Biotech Campus and will be part of the Site Leadership team. The role will work closely with our Research and Development (R&D) and Manufacturing Divisions to create an operating model that integrates late-stage method validation and Quality Control testing for drug candidates manufactured at the Wilmington Biotech Campus. The Laboratory will also support our company's high potent Biologics external network delivering significantly improved speed through the analytical lifecycle. The role will have overall QC responsibility for the Wilmington Biotech Campus. This will involve managing, planning and directing the Quality Control laboratories ensuring compliant laboratory testing. The role will provide the highest quality analytical support for the Wilmington Biotech Campus, while ensuring achievement of supply commitments and safety regulations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees